SFM
ABEO icon

Sphera Funds Management’s Abeona Therapeutics ABEO Stock Holding History

Sphera Funds Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-28,819
Closed -$2.36M – 79
2019
Q4 		$2.36M Buy
+28,819
New +$2.03M 0.19% 73
2019
Q1 		– Sell
-10,801
Closed -$1.93M – 105
2018
Q4 		$1.93M Sell
10,801
-2,677
-20% -$584K 0.22% 74
2018
Q3 		$4.31M Buy
13,478
+4,551
+51% +$1.61M 0.5% 55
2018
Q2 		$3.57M Sell
8,927
-2,873
-24% -$1.26M 0.49% 64
2018
Q1 		$4.23M Buy
11,800
+3,400
+40% +$1.26M 0.64% 49
2017
Q4 		$3.33M Buy
+8,400
New +$3.47M 0.39% 63
2016
Q3 		– Sell
-5,524
Closed -$326K – 107
2016
Q2 		$326K Sell
5,524
-13,198
-70% -$902K 0.08% 86
2016
Q1 		$1.2M Sell
18,722
-5,278
-22% -$350K 0.26% 77
2015
Q4 		$2.02M Hold
24,000
– – 0.3% 85
2015
Q3 		$2.43M Buy
+24,000
New +$3.19M 0.31% 82

Other funds holding ABEO

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sphera Funds Management's ABEO Position: Q1 2020 in Review

Sphera Funds Management sold out of Abeona Therapeutics (ABEO) in Q1 2020, closing a stake of 28,819 shares — an estimated $2.36M sold.

Sphera Funds Management first reported a position in ABEO in Q3 2015 and held it in 10 quarters. The position peaked at $4.31M in Q3 2018. 80 funds tracked by Wall St. Rank hold ABEO as of Q1 2020.

  • Sphera Funds Management reported no remaining Abeona Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Sphera Funds Management sold 28,819 Abeona Therapeutics shares in Q1 2020, an estimated $2.36M.
  • Sphera Funds Management first reported a position in Abeona Therapeutics in Q3 2015 and held it in 10 quarters.
  • Sphera Funds Management's Abeona Therapeutics position peaked at $4.31M in Q3 2018.
  • 80 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2020.

Based on Sphera Funds Management's 13F filing for Q1 2020, filed 14 May 2020.